BioSpace News Archive

The U.S. Food and Drug Administration granted accelerated approval to Brukinsa capsules for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.

BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced that it will report its third quarter 2019 financial results before the opening of the U.S. financial markets on Monday, November 25, 2019.

BrainStorm Cell Therapeutics, Inc. announced that the Company has received a $495,330 grant from the National Multiple Sclerosis Society, through its Fast Forward program, to advance BrainStorm’s Phase 2 open-label, multicenter clinical trial of repeated intrathecal administration of NurOwn® in participants with progressive Multiple Sclerosis

Anavex Life Sciences Corp. announced that it received the Rare Pediatric Disease designation from the U.S. Food and Drug Administration for ANAVEX®2-73 for the treatment of Rett syndrome, a rare genetic neurological disorder associated with severe physical and cognitive impairments that afflicts mostly girls.

Seneca Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, reported its financial results for the three and nine months ended September 30, 2019.

Key Opinion Leaders Will Provide Updated Results on Efficacy, Safety and Delivery of MDNA55

Correvio Pharma Corp., a specialty pharmaceutical company focused on commercializing hospital drugs, reported financial results for its third quarter ended September 30, 2019 and commented on recent accomplishments and plans..

Acerus Pharmaceuticals Corporation reported its financial results for the three- and nine-month period ended September 30, 2019.

Cadent Therapeutics announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the following upcoming investor conferences

The Urology Care Foundation, the world’s leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce Irv Rothman has joined the Foundation Board of Directors